CR20130657A - Ensayo de lisiloxidasa-homólogo 2 y métodos de uso del mismo - Google Patents

Ensayo de lisiloxidasa-homólogo 2 y métodos de uso del mismo

Info

Publication number
CR20130657A
CR20130657A CR20130657A CR20130657A CR20130657A CR 20130657 A CR20130657 A CR 20130657A CR 20130657 A CR20130657 A CR 20130657A CR 20130657 A CR20130657 A CR 20130657A CR 20130657 A CR20130657 A CR 20130657A
Authority
CR
Costa Rica
Prior art keywords
test
lisyloxidase
homologist
methods
same
Prior art date
Application number
CR20130657A
Other languages
English (en)
Spanish (es)
Inventor
Victoria Smith
Joanne I Adamkewicz
Susan K Lyman
Jason Chien
Xiaoming Li
Lixin Shao
Jeffrey D Bornstein
Original Assignee
Gilead Biologics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46208194&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR20130657(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gilead Biologics Inc filed Critical Gilead Biologics Inc
Publication of CR20130657A publication Critical patent/CR20130657A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Silicon Polymers (AREA)
CR20130657A 2011-06-01 2013-12-13 Ensayo de lisiloxidasa-homólogo 2 y métodos de uso del mismo CR20130657A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161492210P 2011-06-01 2011-06-01
US201161550895P 2011-10-24 2011-10-24
US201161578813P 2011-12-21 2011-12-21

Publications (1)

Publication Number Publication Date
CR20130657A true CR20130657A (es) 2014-05-16

Family

ID=46208194

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20130657A CR20130657A (es) 2011-06-01 2013-12-13 Ensayo de lisiloxidasa-homólogo 2 y métodos de uso del mismo

Country Status (25)

Country Link
US (3) US20140206017A1 (https=)
EP (1) EP2714744A1 (https=)
JP (3) JP2014523521A (https=)
KR (1) KR20140048156A (https=)
CN (1) CN103946241A (https=)
AP (1) AP2013007285A0 (https=)
AR (1) AR086657A1 (https=)
AU (2) AU2012261883A1 (https=)
BR (1) BR112013030682A2 (https=)
CA (1) CA2837534A1 (https=)
CL (1) CL2013003445A1 (https=)
CO (1) CO6940375A2 (https=)
CR (1) CR20130657A (https=)
EA (1) EA201391627A1 (https=)
EC (1) ECSP13013092A (https=)
IL (1) IL229631A0 (https=)
MA (1) MA35212B1 (https=)
MD (1) MD20130098A2 (https=)
MX (1) MX2013013905A (https=)
PE (1) PE20141450A1 (https=)
PH (1) PH12013502490A1 (https=)
TW (1) TW201319572A (https=)
UY (1) UY34115A (https=)
WO (1) WO2012167181A1 (https=)
ZA (1) ZA201308812B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030114410A1 (en) 2000-08-08 2003-06-19 Technion Research And Development Foundation Ltd. Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
CA2693310C (en) * 2007-08-02 2018-11-27 Arresto Biosciences, Inc. Lox and loxl2 inhibitors, antibodies and uses thereof
WO2010080769A2 (en) 2009-01-06 2010-07-15 Arresto Biosciences, Inc. Chemotherapeutic methods and compositions
EP2467396A4 (en) 2009-08-21 2012-12-26 Gilead Biologics Inc CATALYTIC DOMAINS FROM LYSYL OXIDASE AND LOXL2
US8680246B2 (en) * 2010-02-04 2014-03-25 Gilead Biologics, Inc. Antibodies that bind to lysyl oxidase-like 2 (LOXL2)
EP3348576A1 (en) * 2012-10-30 2018-07-18 Gilead Sciences, Inc. Therapeutic and diagnostic methods related to lysyl oxidase-like 2 (loxl2)
US20150342943A1 (en) 2014-06-03 2015-12-03 Gilead Sciences, Inc. Methods of treating liver disease
EA201692202A1 (ru) * 2014-06-11 2017-06-30 Джилид Сайэнс, Инк. Способы лечения сердечно-сосудистых заболеваний
MA41252A (fr) 2014-12-23 2017-10-31 Gilead Sciences Inc Formes solides d'un inhibiteur d'ask 1
AU2017228371A1 (en) 2016-03-04 2018-09-13 Gilead Sciences, Inc. Compositions and combinations of autotaxin inhibitors
AU2017248354A1 (en) 2016-04-08 2018-10-04 Gilead Sciences, Inc. Compositions and methods for treating cancer, inflammatory diseases and autoimmune diseases
GB201704206D0 (en) 2017-03-16 2017-05-03 Nordic Bioscience As Lysyl oxidase like-2 assay
US20230152330A1 (en) * 2021-11-17 2023-05-18 AmMax Bio, Inc. Detection and treatment of idiopathic pulmonary fibrosis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6352862B1 (en) * 1989-02-17 2002-03-05 Unilever Patent Holdings B.V. Analytical test device for imuno assays and methods of using same
FI92882C (fi) * 1992-12-29 1995-01-10 Medix Biochemica Ab Oy Kertakäyttöinen testiliuska ja menetelmä sen valmistamiseksi
US20030114410A1 (en) * 2000-08-08 2003-06-19 Technion Research And Development Foundation Ltd. Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
CA2693310C (en) * 2007-08-02 2018-11-27 Arresto Biosciences, Inc. Lox and loxl2 inhibitors, antibodies and uses thereof
JP2010038735A (ja) * 2008-08-05 2010-02-18 Terumo Corp 腹膜機能の評価方法および腹膜機能評価用イムノクロマト試験紙
AU2010283997B2 (en) * 2009-08-21 2015-04-09 Gilead Biologics, Inc. Methods and compositions for treatment of pulmonary fibrotic disorders
US8680246B2 (en) * 2010-02-04 2014-03-25 Gilead Biologics, Inc. Antibodies that bind to lysyl oxidase-like 2 (LOXL2)
US9556882B2 (en) * 2011-05-10 2017-01-31 Borgwarner Inc. Turbocharger with variable turbine geometry

Also Published As

Publication number Publication date
EA201391627A1 (ru) 2014-08-29
JP2018049033A (ja) 2018-03-29
WO2012167181A1 (en) 2012-12-06
CA2837534A1 (en) 2012-12-06
AU2016244254B2 (en) 2018-10-18
AR086657A1 (es) 2014-01-15
ECSP13013092A (es) 2014-08-29
JP2016164578A (ja) 2016-09-08
US20140206017A1 (en) 2014-07-24
CN103946241A (zh) 2014-07-23
CO6940375A2 (es) 2014-05-09
BR112013030682A2 (pt) 2016-12-06
JP2014523521A (ja) 2014-09-11
IL229631A0 (en) 2014-01-30
ZA201308812B (en) 2014-08-27
TW201319572A (zh) 2013-05-16
NZ618682A (en) 2016-04-29
KR20140048156A (ko) 2014-04-23
MX2013013905A (es) 2014-05-14
UY34115A (es) 2013-01-03
US20120309020A1 (en) 2012-12-06
AU2012261883A1 (en) 2013-05-02
AP2013007285A0 (en) 2013-11-30
AU2016244254A1 (en) 2016-11-03
PE20141450A1 (es) 2014-11-06
EP2714744A1 (en) 2014-04-09
US20170269085A1 (en) 2017-09-21
CL2013003445A1 (es) 2014-07-25
MD20130098A2 (ro) 2014-06-30
MA35212B1 (fr) 2014-06-02
PH12013502490A1 (en) 2014-01-20

Similar Documents

Publication Publication Date Title
ECSP13013092A (es) Ensayo de lisiloxidasa-homólogo 2 y métodos de uso del mismo
MX360236B (es) Uso de marcadores en el diagnostico y tratamiento de cancer de prostata.
UY34764A (es) Derivados de 2,2-difluoropropionamida de metilo de bardoxolona, formas polimórficas y sus métodos de uso
AR077237A1 (es) Polimeros colorantes
BR112015001592A8 (pt) análise de imagem e medidas de amostras biológicas
CO2019012771A2 (es) Ensayos de diagnóstico para detectar, cuantificar y/o rastrear microbios y otros analitos
BR112016008970A2 (pt) Método de ativação ex vivo e para avaliar ativação plasmática em um indivíduo, ensaio ex vivo para determinar atividade de calicreína plasmática em uma amostra
AR082388A1 (es) Metodo para identificar un compuesto que tiene un efecto antiarritmico asi como los usos relacionados con el mismo
MX2014011797A (es) Ensayos basados en interrogatorios celulares y uso de los mismos.
MX2017008817A (es) Composiciones y metodos para la glicosilacion de proteinas.
EA201590630A1 (ru) Способы лечения и диагностики, связанные с лизилоксидазоподобным белком 2 (loxl2)
CR20150247A (es) Anticuerpos de antihemaglutinina y métodos de uso
GT201400099A (es) Proteínas que pueden unirse a la il-1
MX2016011377A (es) Metodo para diagnosticar cancer colorrectal a partir de una muestra de heces humanas por pcr cuantitativa, cebadores y equipo.
EA201500080A1 (ru) Способ in vitro диагностирования и мониторинга рака
UY34200A (es) 3-(fluorovinil)pirazoles y su uso
CO2017005773A2 (es) Composiciones, dispositivos, y métodos de pruebas de sensibilidad del ibs
MX2016001719A (es) Metodos y equipos para predecir el riesgo de tener una enfermedad o evento cardiovascular.
BR112014032916A2 (pt) anticorpos anti-fármacos e usos destes para o monitoramento de fármaco
MX2015007213A (es) Formulaciones de la solución de los anticuerpos anti-il-23p19 manipulados genéticamente.
AR087363A1 (es) Uso del anticuerpo i-3859 para la deteccion y diagnostico de los canceres
UY34590A (es) Fenilimidazopirazoles sustituidos y su uso
MX374601B (es) Procedimientos y series para su uso en los mismos.
BR112016002709A2 (pt) queratinas como biomarcadores para câncer cervical e sobrevivência
UY34712A (es) Cabezal procesador y dispositivo de rueda de medición para cabezal procesador .